At 17.1% CAGR, the North America Disposable Endoscope Market is projected to be worth US$ 1,375.08 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the North America disposable endoscope market was valued at US$ 532.15 million in 2022 and is expected to reach US$ 1,375.08 million by 2028, registering a CAGR of 17.1% from 2022 to 2028. Rising incidence of hospital-acquired infections (HAI) due to contaminated endoscopes and increased focus on patient safety and workflow efficiency are the critical factors attributed to the North America disposable endoscope market expansion.

According to an article published in Frontiers in Endoscopy, the US reported ~20 million endoscopic procedures in July 2020, of which 600,000 are endoscopic retrograde cholangiopancreatographies (ERCPs). An increase in the presence of multi-drug resistant organisms (MDRO) on contaminated endoscopes can cause hospital-acquired infections (HAI). In recent years, endoscope-associated infections (EAIs), notably those linked to the reusable endoscopes used for ERCP (e.g., duodenoscope), have been a growing concern in the healthcare system. According to an article published in the National Library of Medicine, in December 2020, the attack rates of duodenoscope-associated outbreaks were between 6% and 20%. The same report concluded that the use of contaminated duodenoscopes during ERCP procedures can cause infections in as many as 10% of procedures. According to an article published in Cambridge University Press, in March 2022, between October 2019 and September 2020, 859 and 850 samples from reprocessed TJF-Q180V and TJF-160F/VF duodenoscopes, respectively, were collected. The overall contamination rate was 5.3%, with 91 samples from both models contaminated by high-concern organisms. According to the American Journal of Infection Control, up to 71% of reprocessed endoscopes can harbor microbial growth, leading to potentially severe complications that can ultimately compromise patient health.

According to an analysis of medical device reports by the US Food and Drug Administration (FDA) received between October 15, 2018, and March 31, 2019, 3 deaths, 45 infection cases, and 159 reports of contaminated devices were recorded due to the insufficient reprocessing of duodenoscopes used in pancreatic and bile duct procedures. Further, it states that Olympus, Fujifilm, and Pentax manufacturers have not complied with post-marketing studies for the reusable endoscopes.

Thus, there is a rising demand for disposable endoscopes across the North America to avoid the cases of HAIs and risks associated with contaminated endoscopes. This is expected to drive the North America disposable endoscope market during the forecast period.

On the contrary, accumulation of medical waste due to disposable endoscopes hurdles the growth of North America disposable endoscope market. 

Based on application, the North America disposable endoscope market is categorized into GI endoscopy, bronchoscopy, urologic endoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held 33.0% share of North America disposable endoscope market in 2022, amassing US$ 175.35 million. It is projected to garner US$ 446.05 million by 2028 to expand at 16.8% CAGR during 2022–2028.

Based on end user, the North America disposable endoscope market is categorized into hospitals, diagnostic centers, and clinics. The hospitals segment held 54.6% share of North America disposable endoscope market in 2022, amassing US$ 290.59 million. It is projected to garner US$ 766.98 million by 2028 to expand at 17.6% CAGR during 2022–2028.

Based on country, the North America disposable endoscope market has been categorized into the US, Canada, and Mexico.  Our regional analysis states that the US captured 71.4% share of North America disposable endoscope market in 2022. It was assessed at US$ 380.08 million in 2022 and is likely to hit US$ 1,007.98 million by 2028, exhibiting a CAGR of 17.7% during the forecast period.            

Key players dominating the North America disposable endoscope market are Boston Scientific Corp; Ambu AS; Consis Medical Ltd; Hill-Rom Services Inc.; Karl Storz SE & Co KG; Flexicare (Group) Ltd; OBP Medical Corp; Prosurg Inc.; and Coloplast Corp among others.

• In Nov 2022, Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
• In Feb 2022, Ambu Announced FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com